dc.contributor.author |
Sharma, Manisha |
en |
dc.contributor.author |
Chandramouli, Kaushik |
en |
dc.contributor.author |
Curley, Louise |
en |
dc.contributor.author |
Pontre, Beau |
en |
dc.contributor.author |
Reilly, Keryn |
en |
dc.contributor.author |
Munro, Jacob |
en |
dc.contributor.author |
Hill, Andrew |
en |
dc.contributor.author |
Young, Simon |
en |
dc.contributor.author |
Svirskis, Darren |
en |
dc.date.accessioned |
2018-10-14T22:12:51Z |
en |
dc.date.issued |
2018-06 |
en |
dc.identifier.issn |
2190-393X |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/41326 |
en |
dc.description.abstract |
Sustained lidocaine release via a thermoresponsive poloxamer-based in situ gelling system has the potential to alleviate pain following knee arthroplasty. A previously developed formulation showed a promising drug release profile in synthetic phosphate-buffered saline (PBS). To support the translation of this formulation, ex vivo characterisation was warranted. This study therefore aimed (1) to modify the previously developed formulation to reduce the burst release, (2) to compare the release behaviour into ex vivo human intra-articular fluid (IAF) and PBS and (3) to determine the formulation spread in an ex vivo human knee using magnetic resonance imaging (MRI). All formulations provided sustained release out to 72 h; polyvinyl pyrrolidone was the most effective additive yielding a small yet significant decrease (p < 0.05) in the burst release. Release of lidocaine from the formulation occurred significantly faster into IAF compared to PBS (1.4 times greater release in the first 24 h), correlating with faster rates of gel erosion in IAF. Injection was easily achieved through a 21-gauge (G) needle into the synovial space of a human cadaveric knee, and MRI scans revealed effective spreading of the formulation throughout the joint cavity. The pattern of spread is promising for the drug to reach the widespread nerve endings in the joint capsule; the effect of this spread on release in an in vivo setting will be the subject of future studies. The demonstrated properties indicate that the in situ gelling formulation has the potential to be used clinically to treat post-operative pain following knee arthroplasty. |
en |
dc.format.medium |
Print |
en |
dc.language |
eng |
en |
dc.relation.ispartofseries |
Drug delivery and translational research |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Knee Joint |
en |
dc.subject |
Humans |
en |
dc.subject |
Poloxamer |
en |
dc.subject |
Lidocaine |
en |
dc.subject |
Povidone |
en |
dc.subject |
Anesthetics, Local |
en |
dc.subject |
Gels |
en |
dc.subject |
Delayed-Action Preparations |
en |
dc.subject |
Magnetic Resonance Imaging |
en |
dc.subject |
Arthroplasty, Replacement, Knee |
en |
dc.subject |
Temperature |
en |
dc.subject |
Drug Liberation |
en |
dc.title |
In vitro and ex vivo characterisation of an in situ gelling formulation for sustained lidocaine release with potential use following knee arthroplasty. |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1007/s13346-018-0492-x |
en |
pubs.issue |
3 |
en |
pubs.begin-page |
820 |
en |
pubs.volume |
8 |
en |
dc.rights.holder |
Copyright: The author |
en |
dc.identifier.pmid |
29411295 |
en |
pubs.end-page |
829 |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Research Support, Non-U.S. Gov't |
en |
pubs.subtype |
Journal Article |
en |
pubs.elements-id |
725218 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
Medical Sciences |
en |
pubs.org-id |
Anatomy and Medical Imaging |
en |
pubs.org-id |
Pharmacy |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
South Auckland clinical school |
en |
pubs.org-id |
Surgery Department |
en |
dc.identifier.eissn |
2190-3948 |
en |
pubs.record-created-at-source-date |
2018-02-08 |
en |
pubs.dimensions-id |
29411295 |
en |